CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2016	Sep. 30, 2015
Operating activities
Net income		$ 179,540	$ 160,493
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		154,308	137,683
Amortization of intangible and other assets and favorable/unfavorable leases		1,566	1,761
Amortization of long-term prepaid rents		1,357	1,901
Amortization of debt issue costs		4,068	3,876
Amortization of deferred revenues, deferred lease incentives and other		(13,017)	(11,959)
Impairment of long-lived assets		2,323	4,955
Share based awards compensation expense		10,247	9,850
Loss on sale of assets and other		10,985	3,852
Write-off of unamortized debt issue costs associated with early retirement of debt		2,369
Deferred lease expenses		(809)	(1,809)
Equity in income of affiliates		(24,597)	(20,372)
Deferred income tax expenses		16,382	(9,570)
Distributions from equity investees	[1]	9,660	12,679
Changes in assets and liabilities and other		(76,102)	(67,003)
Net cash provided by operating activities		278,280	226,337
Investing activities
Additions to theatre properties and equipment and other		(230,346)	(232,351)
Proceeds from sale of theatre properties and equipment and other		3,398	6,283
Proceeds from sale of marketable securities		13,451
Investment in joint ventures and other		(1,703)	(3,180)
Net cash used for investing activities		(230,500)	(231,899)
Financing activities
Dividends paid to stockholders		(94,117)	(86,882)
Payroll taxes paid as a result of restricted stock withholdings		(6,828)	(4,770)
Proceeds from issuance of Senior Notes, net of discount		222,750
Retirement of Senior Subordinated Notes		(200,000)
Repayments of long-term debt		(15,217)	(5,274)
Payment of debt issue costs		(4,504)	(6,957)
Payments on capital leases		(14,655)	(12,201)
Other		1,282	2,123
Net cash used for financing activities		(111,289)	(113,961)
Effect of exchange rate changes on cash and cash equivalents		2,081	(16,432)
Decrease in cash and cash equivalents		(61,428)	(135,955)
Cash and cash equivalents:
Beginning of period		588,539	638,869
End of period		527,111	502,914
Brazil
Investing activities
Acquisition of theatres			$ (2,651)
U.S.
Investing activities
Acquisition of theatres		$ (15,300)

[1] Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow, which provides our chief operating decision maker with more comprehensive cash flow information, and for consistency with our peers, beginning with the three months ended March 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the three and nine months ended September 30, 2015 has been adjusted to reflect comparable presentations.